Inspiratory muscle training for children with beta thalassemia
Inspiratory Muscle Training in Children With Beta Thalasemia
NA · Ahram Canadian University · NCT06466304
This study tests if special breathing exercises can help children with beta thalassemia breathe better and improve their lung function.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 8 Years to 12 Years |
| Sex | All |
| Sponsor | Ahram Canadian University (other) |
| Locations | 1 site (Giza) |
| Trial ID | NCT06466304 on ClinicalTrials.gov |
What this trial studies
This study focuses on children diagnosed with beta thalassemia major, who often experience respiratory complications. It involves assigning 40 participants to either an inspiratory muscle training group or a waiting list group, with each training group receiving two sessions per day using a threshold inspiratory muscle trainer for 12 weeks. The goal is to decrease respiratory issues and improve pulmonary function through targeted training.
Who should consider this trial
Good fit: Ideal candidates are children diagnosed with beta thalassemia major who do not have any significant respiratory or cardiac diseases.
Not a fit: Patients with existing respiratory, cardiac, renal, liver, or muscle and joint diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance respiratory health and quality of life for children with beta thalassemia major.
How similar studies have performed: While inspiratory muscle training has shown promise in other populations, this specific application in children with beta thalassemia major is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 40 beta thalassemia major children * boys and girls Exclusion Criteria: * respiratory diseases * cardiac diseases renal diseases liver diseases muscle and joint disease
Where this trial is running
Giza
- Ahram canadian university — Giza, Egypt (RECRUITING)
Study contacts
- Principal investigator: hagar el-hadidy, lecturer — Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt
- Study coordinator: hagar el-hadidy, lecturer
- Email: hagarhadidy2016@gmail.com
- Phone: 020100 745 3552
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Beta Thalassemia Major